Abstract
A method of epitope analysis is described in which the binding of one monoclonal antibody (MAb) to radiolabeled carcinoembryonic antigen (CEA) competes with the subsequent binding of an immobilised second MAb. From the degree of blocking obtained, we have identified both structurally related and independent epitopes on CEA. Using this technique to study fifteen MAbs, we have been able to recognise at least 6 unrelated epitopes of the CEA glycoprotein. Further characterisation of these epitopes was accomplished by means of immunohistochemistry. Of the fifteen MAbs, 6 were specific for CEA and reacted with at least 3 unrelated regions of the glycoprotein. Of the remaining 9 MAbs, 2 cross-reacted with erythrocytes, 5 with components of liver and 7 with polymorphonuclear neutrophils. Cross-reactions with liver were varied showing differential antibody specificity for bile canaliculi, Kupffer cells and bile duct epithelium. A high degree of correlation between epitope relatedness and immunohistochemical specificity was found. Two CEA-specific and 4 cross-reactive MAbs were also shown to react with ion-sensitive sites on the CEA glycoprotein.
MeSH Terms
Adenocarcinoma/immunology
Animals
Antibodies, Monoclonal/immunology
Antigen-Antibody Reactions
Binding Sites, Antibody
Binding, Competitive
Carcinoembryonic Antigen/immunology
Colonic Neoplasms/immunology
Cross Reactions
Epitopes/analysis
Liver/immunology
Mice
Spleen/immunology
Chemicals
Antibodies, Monoclonal
Carcinoembryonic Antigen
Epitopes
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Harwood P J
Britton D W
Southall P J
Boxer G M
Rawlins G
Rogers G T
References (15)
15 references, click to expand
-
Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen.
Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492-4
PMID: 4115954
-
DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.
J Exp Med. 1965 Mar 1;121:439-62
PMID: 14270243
-
Biochemical monitoring of cancer. A review.
Ann Clin Biochem. 1976 Jan;13(1):283-305
PMID: 56153
-
Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues.
Eur J Cancer. 1975 Nov;11(11):783-6
PMID: 767110
-
Carcinoembryonic antigen-like substances of human bile. Isolation and partial characterization.
Int J Cancer. 1976 May 15;17(5):588-96
PMID: 57933
-
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.
Biochem Biophys Res Commun. 1978 Feb 28;80(4):849-57
PMID: 637870
-
Tissue preparation for the demonstration of surface antigen by immunoperoxidase techniques.
Histochem J. 1982 Sep;14(5):747-53
PMID: 6752105
-
Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.
Cancer Res. 1983 Feb;43(2):693-701
PMID: 6184153
-
Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.
Cancer Res. 1983 Aug;43(8):3857-64
PMID: 6344991
-
Binding studies on two different monoclonal antibodies raised against CEA.
Eur J Cancer Clin Oncol. 1983 May;19(5):629-39
PMID: 6683635
-
Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity.
Biochim Biophys Acta. 1983 Dec 29;695(3-4):227-49
PMID: 6360209
-
Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.
Cancer Res. 1984 May;44(5):2213-8
PMID: 6713409
-
A monoclonal antibody against a CEA-related antigen expressed on HT29 colon tumour cells.
Eur J Cancer Clin Oncol. 1984 Oct;20(10):1279-86
PMID: 6208034
-
Recent advances in tumour imaging. Use of radiolabelled antitumour antibodies.
Biochim Biophys Acta. 1985;780(2):151-66
PMID: 2988609
-
Characterization of a second normal antigen that cross-reacts with CEA.
J Immunol. 1973 Dec;111(6):1926-8
PMID: 4356327